Faaamed

Cancer

Cannabis has emerged as a complementary option in managing cancer-related symptoms, providing relief from pain, nausea, and inflammation while potentially inhibiting tumor growth. Cannabinoids like tetrahydrocannabinol (THC) and cannabidiol (CBD) interact with the endocannabinoid system to reduce chronic pain, a common challenge for cancer patients (Portenoy et al., 2012). Moreover, cannabis has demonstrated efficacy in alleviating chemotherapy-induced nausea and vomiting, offering an alternative to traditional antiemetics (Abrams et al., 2011). Studies also suggest that cannabinoids possess anti-inflammatory and antioxidative properties, which may contribute to slowing cancer progression (Velasco et al., 2016).

Preclinical research has shown that THC and CBD can induce apoptosis (programmed cell death) in cancer cells while sparing healthy cells, though clinical trials are needed to confirm these findings (Guzmán, 2003). Additionally, cannabis can improve appetite and quality of life for patients experiencing cachexia, a severe weight-loss condition associated with cancer (Strasser et al., 2006). While cannabis shows promise as a supportive therapy, its use should be under medical supervision to ensure safety and efficacy. Ongoing research is critical to fully understand its role in cancer treatment and establish evidence-based guidelines.

References

  1. 1. Abrams, D. I., Guzman, M., & Licinio, J. (2011). Cannabis in cancer care. Current Oncology, 18(3), e146-e149.
  2. 2. Guzmán, M. (2003). Cannabinoids: potential anticancer agents. Nature Reviews Cancer, 3(10), 745-755.
  3. 3. Portenoy, R. K., Ganae-Motan, E. D., & Allende, S. (2012). Cannabis for pain and symptom management. The Journal of Pain, 13(4), 456-466.
  4. 4. Strasser, F., Luftner, D., & Fainsinger, R. (2006). Appetite enhancement in advanced cancer patients. Journal of Clinical Oncology, 24(8), 1397-1402.
  5. 5. Velasco, G., Sánchez, C., & Guzmán, M. (2016). Towards the use of cannabinoids as antitumor agents. Nature Reviews Cancer, 16(3), 190-198.

Related Services

Bipolar

Cannabis has garnered attention as a potential adjunct therapy for bipolar disorder, offering therapeutic benefits when used…

Crohn's Disease

Cannabis has shown promise as a therapeutic option for managing Crohn’s disease, a chronic…

Chronic Pain (Anywhere)

Cannabis has gained recognition as a potential therapy for managing chronic pain, offering relief…

Deppression

Cannabis is being explored as a potential adjunct therapy for managing depression, offering…

Epilepsy

Cannabis, particularly cannabidiol (CBD) has shown significant promise in managing epilepsy,…

Glaucoma

Cannabis has been explored as a potential treatment for glaucoma, a condition characterized…

Gout (Pain)

Cannabis is being studied as a potential therapy for managing pain associated with gout, a form of…

Graves Disease

Cannabis is being explored as a complementary therapy for managing symptoms associated with….

HIV/AIDS

Cannabis has demonstrated potential in improving the quality of life for individuals living with..

Hypertension

Cannabis has been studied for its potential to help manage hypertension (high blood pressure), a…

IBS (Irritable Bowel Syndrome)

Cannabis has gained as a potential treatment for Irritable Bowel Syndrome (IBS),  a gastrointestinal disorder…

Insomnia

Cannabis has gained attention as a potential treatment for insomnia, a common sleep disorder..

Migraines

Cannabis has shown potential in the treatment of migraines, a neurological condition characterized…

Multiple Sclerosis

Cannabis has shown potential as a therapeutic option for managing symptons of multiple sclerosis (MS), a chronic…